AI in Diabetes Management: Global Market Outlook
Report Scope:
In this report, the market has been segmented based on product type, technique and geographic region. The report provides an overview of the global market for AI in diabetes management and analyzes market trends. Using 2021 as the base year, the report provides estimated market data and revenue projections for the forecast period of 2022-2027. Market values have been estimated based on the total revenue of providers of AI in diabetes management products.
The scope of the study includes AI in diabetes management care platforms and associated services.
Report Includes:
A brief general outlook of the global market for artificial intelligence (AI) in diabetic management
Analyses of the global market trends, with historic market revenue for 2021, estimates for 2022, forecasts for 2023 and 2025, and projections of compound annual growth rates (CAGRs) through 2027
Understanding of the upcoming market potential for AI in diabetic mellitus management with an emphasis on new products and solutions/platform technologies, and areas of focus to forecast this market into various segments and sub-segments
Estimation of the actual market size and revenue forecast for the AI in diabetic management market, and corresponding market share analysis product type, technique, and region
In-depth information (facts and figures) on the major market dynamics, opportunities and gaps estimating the demand, technology adaptations in diabetes care, industry developments, regulatory dynamics, and Covid-19 impact on the progress of this market
Identification of the companies best positioned to meet this demand owing to or in conjunction with their proprietary technologies, product launches, and other strategic advantages
Company profiles of the major global players
Companies Mentioned
ABBOTT
BIGFOOT BIOMEDICAL INC.
CARDINAL HEALTH INC.
DREAMED DIABETES LTD.
EYENUK INC.
GLOOKO INC.
GOOGLE INC.
HEALTH ARX TECHNOLOGIES PRIVATE LTD.
MEDTRONIC
Virta Health Corp.
- Chapter 1 Market Outlook
- 1.1 Market Snapshot
- Chapter 2 Executive Summary
- Chapter 3 Market Overview
- 3.1 Overview
- 3.1.1 Role of AI in Diabetes Care
- 3.1.2 Applications for AI in Diabetes Management
- 3.2 Future of AI in Diabetes Management
- 3.3 Market Dynamics
- 3.3.1 Market Drivers
- 3.3.2 Market Restraints
- 3.3.3 Market Challenges
- 3.4 Macroeconomic Factors of AI in Diabetes Management
- 3.4.1 Impact of COVID-19 Pandemic
- 3.4.2 Impact of Russia-Ukraine War
- Chapter 4 Market Opportunities
- 4.1 Market Opportunities
- 4.1.1 Growing Adoption of AI for Eye Care
- 4.1.2 Growing Number of Starts-ups Targeting Diabetes Care
- Chapter 5 Market Breakdown by Product Type and Technique
- 5.1 AI in Diabetes Management Market, by Product Type
- 5.1.1 Glucose Monitoring Devices
- 5.1.2 Diagnostic Devices
- 5.1.3 Insulin Delivery Devices
- 5.2 AI in Diabetes Management Market, by Technique
- 5.2.1 Case-based Reasoning
- 5.2.2 Intelligent Data Analysis
- Chapter 6 Market Breakdown by Region
- 6.1 Overview
- 6.2 North America
- 6.3 Europe
- 6.4 Asia-Pacific
- 6.5 Latin America
- 6.6 Middle East and Africa
- Chapter 7 Company Profiles
- ABBOTT
- BIGFOOT BIOMEDICAL INC.
- CARDINAL HEALTH INC.
- DREAMED DIABETES LTD.
- EYENUK INC.
- GLOOKO INC.
- GOOGLE INC.
- HEALTH ARX TECHNOLOGIES PRIVATE LTD.
- MEDTRONIC
- VIRTA HEALTH CORP.
- Chapter 8 Project Scope and Methodology
- 8.1 Scope of Report
- 8.2 Methodology
- 8.3 Geographic Breakdown
- 8.4 Analyst's Credentials
- 8.5 Related BCC Research Reports
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook